100 employees
Avineuro Pharmaceuticals discovers and develops novel small molecules for unmet medical needs in neurology and psychiatry.
2008
Avineuro Pharmaceuticals, Inc. raised undisclosed on May 11, 2011
Investors: Torrey Pines Investment